| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 97.31B | 127.47B | 180.74B | 250.57B | 223.38B |
| Gross Profit | 9.43B | 20.41B | 30.58B | 53.04B | 56.54B |
| EBITDA | 3.16B | 12.14B | 20.24B | 41.42B | 40.65B |
| Net Income | 1.02B | 10.40B | 12.85B | 24.36B | 23.85B |
Balance Sheet | |||||
| Total Assets | 596.12B | 665.64B | 700.41B | 786.77B | 875.65B |
| Cash, Cash Equivalents and Short-Term Investments | 29.21B | 38.40B | 59.23B | 72.13B | 88.19B |
| Total Debt | 166.01B | 206.69B | 207.48B | 224.77B | 228.48B |
| Total Liabilities | 359.01B | 420.16B | 463.95B | 553.60B | 653.77B |
| Stockholders Equity | 162.88B | 161.43B | 151.97B | 142.10B | 124.95B |
Cash Flow | |||||
| Free Cash Flow | 21.83B | 29.41B | 32.16B | 9.66B | 28.00B |
| Operating Cash Flow | 21.88B | 29.75B | 33.01B | 9.96B | 28.53B |
| Investing Cash Flow | -4.25B | -11.60B | -11.61B | -12.41B | -48.73B |
| Financing Cash Flow | -38.22B | -29.42B | -34.27B | -13.56B | 31.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$396.13B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
73 Outperform | HK$256.14B | 3.64 | 8.80% | 5.18% | 1.05% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$59.11B | -6.27 | 0.65% | 3.96% | -23.93% | -90.51% | |
58 Neutral | HK$174.24B | 10.85 | 3.54% | 4.54% | -9.39% | -19.08% | |
46 Neutral | HK$11.71B | 0.12 | -3.01% | ― | -38.67% | ― | |
41 Neutral | HK$47.69B | -1.28 | -59.37% | ― | -28.73% | -60.86% |